Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic HPV Vaccine (BNT113) Trial in HPV16 Driven Carcinoma

NCT03418480 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

NCT NCT03418480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic HPV Vaccine (BNT113) Trial in HPV16 Driven Carcinoma
Lead sponsor
University of Southampton
Phase
Phase 1/2
Overall status
Completed
Start date
April 11, 2017
Completion date
January 24, 2024
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical neoplasm, head and neck neoplasm, human papilloma virus related carcinoma, penile neoplasms malignant, unknown primary tumors